Interestingly, a larger than expected number of thrombotic events were reported in COVID‐19 patients (Ahmed, Zimba, & Gasparyan, 2020), and elevated plasminogen active inhibitor‐1 (PAI‐1) is an independent risk factor for poor ARDS outcomes. This evidence concerns the gene SERPINE1 and COVID-19.